Viewing Study NCT01484093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:18 PM
Study NCT ID: NCT01484093
Status: COMPLETED
Last Update Posted: 2023-08-16
First Post: 2011-11-29
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CYCLOPHOSPHAMIDE (CYTOXAN) View
None CYTARABINE (ARA-C) View
None DOXORUBICIN/ADRIAMYCIN View
None PREDNISONE View
None RITUXIMAB View
None TOSITUMOMAB (BEXXAR) View
None Iodine View
None VINCRISTIN View
None Lymphoma View
None Chemo-Radioimmunotherapy View
None Autologous Transplantation View
None Untreated View
None 11-095 View